Verition Fund Management
IMUX icon

Verition Fund Management’s Immunic IMUX Stock Holding History

Verition Fund Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-24,531
Closed -$361K – 2502
2023
Q3 		$361K Sell
24,531
-37,238
-60% -$716K ﹤0.01% 1624
2023
Q2 		$1.55M Buy
61,769
+7,604
+14% +$127K 0.02% 788
2023
Q1 		$807K Buy
54,165
+1,402
+3% +$26K 0.01% 1030
2022
Q4 		$739K Sell
52,763
-17,130
-25% -$467K 0.01% 1060
2022
Q3 		$2.21M Buy
69,893
+8,916
+15% +$373K 0.02% 845
2022
Q2 		$2.12M Buy
60,977
+46,845
+331% +$3M 0.04% 626
2022
Q1 		$1.6M Sell
14,132
-5,029
-26% -$582K 0.02% 1133
2021
Q4 		$1.83M Buy
+19,161
New +$1.73M 0.01% 943
2021
Q2 		– Sell
-2,469
Closed -$394K – 2009
2021
Q1 		$394K Sell
2,469
-5,497
-69% -$932K ﹤0.01% 977
2020
Q4 		$1.22M Buy
7,966
+3,502
+78% +$629K 0.01% 473
2020
Q3 		$829K Sell
4,464
-4,678
-51% -$766K 0.02% 424
2020
Q2 		$1.11M Buy
9,142
+8,012
+709% +$815K 0.04% 386
2020
Q1 		$67K Hold
1,130
– – ﹤0.01% 535
2019
Q4 		$110K Hold
1,130
– – ﹤0.01% 1007
2019
Q3 		$114K Buy
+1,130
New +$151K ﹤0.01% 977

Other funds holding IMUX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Verition Fund Management's IMUX Position: Q4 2023 in Review

Verition Fund Management sold out of Immunic (IMUX) in Q4 2023, closing a stake of 24,531 shares — an estimated $361K sold.

Verition Fund Management first reported a position in IMUX in Q3 2019 and held it in 15 quarters. The position peaked at $2.21M in Q3 2022. 49 funds tracked by Wall St. Rank hold IMUX as of Q4 2023.

  • Verition Fund Management reported no remaining Immunic position as of Q4 2023 after selling out during the quarter.
  • Verition Fund Management sold 24,531 Immunic shares in Q4 2023, an estimated $361K.
  • Verition Fund Management first reported a position in Immunic in Q3 2019 and held it in 15 quarters.
  • Verition Fund Management's Immunic position peaked at $2.21M in Q3 2022.
  • 49 funds tracked by Wall St. Rank held Immunic as of Q4 2023.

Based on Verition Fund Management's 13F filing for Q4 2023, filed 14 Feb 2024.